ACADIA PHARMACEUTICALS A/S: Financial statements 2025
CVR: 19670694
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.
- Profit/Loss
- DKK -471,043
- Equity
- DKK -1,563,180
- Total Assets
- DKK 14,101
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -471K | -1.6M | 0 |
| 2024 | - | - | -99K | -1.1M | 0 |
| 2023 | - | -151K | -151K | -993K | 0 |
| 2022 | - | -254K | -254K | -841K | 0 |
| 2021 | - | -21K | -21K | -588K | 0 |
Official annual report
How creditworthy is ACADIA PHARMACEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ACADIA PHARMACEUTICALS A/S has published its annual report for 2024. The net result was DKK -99,365.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.